Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Acq. announced
CC transcript
MADRIGAL PHARMACEUTICALS, INC. (MDGL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Quarterly results
Docs: "Madrigal Pharmaceuticals Provides Corporate Updates and Reports Second Quarter 2023 Financial Results"
05/09/2023 8-K Quarterly results
Docs: "Madrigal Pharmaceuticals Provides Corporate Updates and Reports First Quarter 2023 Financial Results"
08/04/2022 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Madrigal Pharmaceuticals Provides Clinical and Business Updates and Reports 2022 Second Quarter Financial Results"
05/09/2022 8-K Quarterly results
11/04/2021 8-K Quarterly results
Docs: "Madrigal Pharmaceuticals Provides Corporate Update and Reports 2021 Third Quarter Financial Results"
08/05/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
02/25/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "Madrigal Pharmaceuticals Announces Completion of Enrollment in Phase 3 MAESTRO NAFLD-1 Trial and Reports 2020 Third Quarter Financial Results and Highlights"
08/06/2020 8-K Quarterly results
05/07/2020 8-K Quarterly results
02/26/2020 8-K Quarterly results
11/06/2019 8-K Quarterly results
08/07/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Madrigal Pharmaceuticals Reports 2019 Second Quarter Financial Results and Highlights"
05/08/2019 8-K Quarterly results
Docs: "Madrigal Pharmaceuticals Reports 2019 First Quarter Financial Results and Highlights"
02/27/2019 8-K Quarterly results
11/06/2018 8-K Quarterly results
Docs: "Madrigal Pharmaceuticals Reports 2018 Third Quarter Financial Results and Highlights Upcoming Clinical Events"
08/07/2018 8-K Quarterly results
Docs: "Madrigal Pharmaceuticals Reports 2018 Second Quarter Financial Results and Reviews Key Clinical Achievements"
05/08/2018 8-K Quarterly results
Docs: "Madrigal Pharmaceuticals Reports 2018 First Quarter Financial Results and Reviews Key Clinical Achievements"
03/13/2018 8-K Quarterly results
Docs: "Madrigal Pharmaceuticals Reports 2017 Fourth Quarter and Year-End Financial Results, Reviews Key Corporate Achievements and Provides Clinical Update on MGL-3196"
11/09/2017 8-K Quarterly results
Docs: "Madrigal Pharmaceuticals Reports 2017 Third Quarter Financial Results"
08/10/2017 8-K Quarterly results
05/11/2017 8-K Form 8-K - Current report
04/03/2017 8-K Form 8-K - Current report
11/14/2016 8-K Quarterly results
Docs: "MADRIGAL REPORTS THIRD QUARTER 2016 FINANCIAL RESULTS -Successfully Completed Merger and Transition to Public Company- - Initiated Phase II study in NASH - - Out-licensed non-core asset HSP90 to Tarveda Therapeutics -"
03/26/2009 8-K Form 8-K -- Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy